Home / Uncategorized / Cystic fibrosis drug Kalydeco approved by FDA: What does it mean for patients?

Cystic fibrosis drug Kalydeco approved by FDA: What does it mean for patients?

November study found Kalydeco improved lung function, reduced complications in patients with cystic fibrosis who have G551D mutation

Go here to see the original:
Cystic fibrosis drug Kalydeco approved by FDA: What does it mean for patients?

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top